Search

everythinglearnresearchcommunity

for

Search:↓

These medications for BPH have known risks and may have new side effects.

The higher dose supplement was more effective in treating female hair loss.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride may help treat female hair loss, but has risks.

Isoflavones may help with menopause symptoms but could be risky for women with hormone-sensitive cancers.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

17β-estradiol boosts APE1/Ref-1 secretion in cells and mice via a calcium-dependent pathway.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Spironolactone may be a better acne treatment for adult women than antibiotics.

Finasteride may increase the risk of suicidality and depression, especially in younger people.

Monitoring for adverse effects in clinical treatments is crucial.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Women also use 5α-reductase inhibitors for hair loss and hirsutism.

Oral minoxidil may have more cardiovascular risks than topical minoxidil.